PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-28

Date Title Company
28-Oct-2025 Prepare for 340B's Rebate Model Pilot Program ACCESS Newswire
28-Oct-2025 Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series ACCESS Newswire
28-Oct-2025 Beauty-Stem's "Beauty Beyond Age" Forum ACCESS Newswire
28-Oct-2025 Crushed No More? Whole Tablets Safe in Stroke Dysphagia Karl Landsteiner University (KL Krems)
28-Oct-2025 Symbiosis Builds Global Business Development Strength with Two North American Appointments Symbiosis
28-Oct-2025 Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) ACCESS Newswire
28-Oct-2025 Tricuspid Valve Repair Market Research, Size, Share and Trends, Growth Forecast to 2028 Medi-Tech Insights
28-Oct-2025 NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer Bayer
28-Oct-2025 Who is Javad Sajan? ACCESS Newswire
28-Oct-2025 ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices ViiV Healthcare
28-Oct-2025 Publication of Landmark Study in JACC: Advances ACCESS Newswire
28-Oct-2025 Mechanical Thrombectomy Devices Market Size, Share and Research Report Forecast, 2030 Medi-Tech Insights
28-Oct-2025 Lundbeck and OpenAI join forces to unlock innovation and boost productivity Lundbeck, OpenAI
28-Oct-2025 BIMZELX® (bimekizumab-bkzx) three year rheumatology data at ACR 2025 demonstrated sustained inflammation control in psoriatic arthritis and axial spondyloarthritis UCB
28-Oct-2025 Biobeat report predicts CDMOs in China & USA to see fastest growth – with mAbs, PROTACs, ADCs & sterile filling in demand Biobeat
28-Oct-2025 ViCentra Strengthens Leadership Team to Accelerate Growth ViCentra
28-Oct-2025 Domain Therapeutics Doses First Patients in Phase I/II Trial of DT-7012 Targeting CCR8 in Solid Tumors Domain Therapeutics
28-Oct-2025 Model N survey shows consumers are interested in DTC drugs — if the price is right Model N
28-Oct-2025 Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA ACCESS Newswire
28-Oct-2025 Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA ACCESS Newswire